All Stories

  1. Celiac Disease: A Common Unrecognized Health Problem with a Very Delayed Diagnosis
  2. The effect of Betanin parenteral pretreatment on Jejunal and pulmonary tissue histological architecture and inflammatory response after Jejunal ischemia-reperfusion injury
  3. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma
  4. Eosinophilic esophagitis: An evidenced-based approach to diagnosis and treatment
  5. The role of dietary phytochemicals in the carcinogenesis via the modulation of miRNA expression
  6. Markers of Atherosclerosis: Part 1 – Serological Markers
  7. Markers of Atherosclerosis: Part 2 – Genetic and Imaging Markers
  8. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment
  9. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review
  10. Impact of drugs on venous thromboembolism risk in surgical patients
  11. Descriptive Study of the Different Tools Used to Evaluate the Adherence to a Gluten-Free Diet in Celiac Disease Patients
  12. Evaluation of Efficacy and Adherence to Gluten-Free Diet in Patients with Celiac Disease
  13. Cutaneous and Mucosal Manifestations Associated with Celiac Disease
  14. Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma
  15. Cutaneous and Mucosal Manifestations Associated to Celiac Disease
  16. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study
  17. Novel inflammatory biomarkers
  18. Efficacy of a Gluten-Free Diet in the Gilles de la Tourette Syndrome: A Pilot Study
  19. Faecal Calprotectin
  20. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts
  21. Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa
  22. Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women
  23. Inducible nitric oxide synthase: Good or bad?
  24. Celiac Disease and Non-Celiac Gluten Sensitivity
  25. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
  26. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches
  27. Effects of polyphenol compounds melanin on NAFLD/NASH prevention
  28. Cyp2c19 Genotype and Response to Proton Pump Inhibitor Therapy in Naãÿve Adult Patients with Eosinophilic Esophagitis
  29. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease
  30. Downregulation of myogenic microRNAs in sub-chronic but not in sub-acute model of daunorubicin-induced cardiomyopathy
  31. Human Helminthiasis
  32. Nanocrystalline cerium dioxide efficacy for prophylaxis of erosive and ulcerative lesions in the gastric mucosa of rats induced by stress
  33. Chili pepper as a body weight-loss food
  34. Perspectives and challenges of antioxidant therapy for atrial fibrillation
  35. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade
  36. Colorectal Cancer - From Pathogenesis to Treatment
  37. Erratum to: Biosensors for the Diagnosis of Celiac Disease: Current Status and Future Perspectives
  38. Effect of Low Dose Atorvastatin Therapy on Baroreflex Sensitivity in Hypertensives
  39. Biosensors for the Diagnosis of Celiac Disease: Current Status and Future Perspectives
  40. Tu1335 European Registry on H. pylori Management (HP-EuReg) in Spain: Interim Analysis in First and Second Line Therapies
  41. Gluten ataxia is better classified as non-celiac gluten sensitivity than as celiac disease: a comparative clinical study
  42. Protective effect of ischemic preconditioning on the jejunal graft mucosa injury during cold preservation
  43. Epidemiology of Celiac Disease and Non-Celiac Gluten-Related Disorders
  44. Extraintestinal Manifestations of Celiac Disease and Associated Disorders
  45. The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators—A pilot study
  46. P0521 : Characterization and validation of angiogenic genetic variants related to chronic hepatitis C progression to hepatocellular carcinoma
  47. The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism
  48. Etiology of Pancreatitis and Risk Factors
  49. Acute and Chronic Pancreatitis
  50. Anaemia due to gastric haemorrhage by a metastatic Merkel cell carcinoma
  51. Celiac Disease and Non-Celiac Gluten Sensitivity
  52. Celiac Disease and Non-Celiac Gluten Sensitivity
  53. Extraintestinal Manifestations and Associated Diseases
  54. Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study
  55. Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis)
  56. Comments on ‘Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia’ by Vanheelet al
  57. P773 ANGIOGENIC BIOMARKERS OF CHRONIC HEPATITIS C PROGRESSION TO HEPATOCELLULAR CARCINOMA
  58. P219 FINE MAPPING OF THE BUTYROPHILIN GENOMICS REGION: ROLE IN HEPATITIS C VIRUS INFECTION (HCV)
  59. Autoantibodies against MHC class I polypeptide-related sequence A are associated with increased risk of concomitant autoimmune diseases in celiac patients
  60. Response to ‘Remarkable prevalence of celiac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study’ – authors’ reply
  61. Transcultural adaptation and validation of the Celiac Disease Quality of Life (CD-QOL) survey, a specific questionnaire to measure quality of life in patients with celiac disease
  62. Clinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac disease
  63. Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
  64. Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition
  65. Manifestaciones extra-intestinales y enfermedades asociadas
  66. Enfermedad celíaca y sensibilidad al gluten no celíaca
  67. Enfermedad celíaca y sensibilidad al gluten no celíaca
  68. 854 POLYMORPHISMS IN HISTONE DEACETYLASES IMPROVE THE PREDICTIVE VALUE OF IL-28B FOR CHRONIC HEPATITIS C THERAPY
  69. Urticaria pigmentosa in a female patient with celiac disease: Response to a gluten-free diet
  70. Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection
  71. Annual Incidence of Hepatocellular Carcinoma Among Patients With Alcoholic Cirrhosis and Identification of Risk Groups
  72. Celiac Disease and Autoimmune-Associated Conditions
  73. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study
  74. Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors
  75. Situación actual del manejo de la hemorragia digestiva alta no varicosa en España
  76. Multiple Sclerosis and Celiac Disease
  77. A predictive model of treatment outcome in patients with chronic HCV infection using IL28B and PD-1 genotyping
  78. 924 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED A NOVEL SUSCEPTIBILITY LOCUS GENE PBK (RS 17388536)FOR SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS BEARING IL28B GENOTYPE CC
  79. 908 FACTORS INVOLVED IN SUSTAINED VIRAL RESPONSE (SVR) ACHIEVEMENT IN PATIENTS WITH FAVORABLE IL28B CC GENOTYPE IN HEPATITIS C
  80. 904 HOST GENETIC VARIANTS IN INTERFERON SIGNALING PATHWAY RELATED TO NECROINFLAMMATORY ACTIVITY IN CHRONIC HEPATITIS C
  81. 923 INTERACTION BETWEEN RS12979860 POLYMORHISM OF IL28B GENE WITH BASELINE PREDICTIVE FACTORS OF RESPONSE TO TREATMENT IN PATIENTS WITH HEPATITIS C
  82. Pancreatitis - Treatment and Complications
  83. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
  84. Acute Pancreatitis
  85. Osteogenesis Imperfecta with Celiac Disease and Type II Diabetes Mellitus Associated: Improvement with a Gluten-Free Diet
  86. Porphyria cutanea tarda with multiple nodular foci in the liver
  87. Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures
  88. Helicobacter pylori Levofloxacin-Based Rescue Option in Patients Allergic to Penicillin Failing a Previous Treatment With Clarithromycin and Metronidazole
  89. Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure. Time Trends of Eradication in a Spanish Multicenter Study of 830 Patients
  90. Prevalence of celiac disease in multiple sclerosis
  91. NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system
  92. Coeliac Disease in the 21st Century: No Longer “Kids’ Stuff”
  93. Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia
  94. Neurogluten: patología neurológica por intolerancia al gluten
  95. Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations†
  96. Acute and chronic effect of copper on levels of reduced and oxidized glutathione and nutrient uptake of tomato plants
  97. Kaposi's sarcoma: An opportunistic infection by human herpesvirus-8 in ulcerative colitis
  98. Síndrome de Down y enfermedad celíaca del adulto asociadas: estudio de 9 casos
  99. Adult Patients with Eosinophilic Esophagitis Do Not Show an Increased Frequency of the HLA-DQ2/DQ8 Genotypes Predisposing to Celiac Disease
  100. Respuesta
  101. Gluten sensitivity and the CNS: diagnosis and treatment
  102. Síndrome de Turner y enfermedad celíaca del adulto
  103. STAT4 gene influences genetic predisposition to ulcerative colitis but not Crohn's disease in the Spanish population: A replication study
  104. S1396: An Intensive Bowel Cleansing Strategy for Patients With Previous Colonoscopy Preparation Failure: Results of a Prospective Study
  105. Sp271: Gastric Endoscopic Submucosal Dissection (ESD) with a New Traction Method: The Clip-Band Technique
  106. ITER operating limit definition criteria
  107. CD8dim and NKG2D Expression Defines Related Subsets of CD4+ T cells in HIV-Infected Patients With Worse Prognostic Factors
  108. Tuberculosis peritoneal por Mycobacterium bovis en paciente cirrótico
  109. Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
  110. Respuesta de los autores
  111. Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories
  112. Enfermedad celíaca
  113. Enfermedad celíaca
  114. Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility
  115. Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
  116. Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C
  117. Sustained improvement of health-related quality of life in Crohnʼs disease patients treated with infliximab and azathioprine for 4 years
  118. The allele MICB*0050204, over-represented in the Caucasian population, has an additional exon resulting from a new splice junction sequence
  119. Transcriptional regulation of MICA and MICB: A novel polymorphism in MICB promoter alters transcriptional regulation by Sp1
  120. [558] ASSESSMENT OF FIBROSIS DISTRIBUTION IN PATIENTS WITH CHRONIC HEPATITIS C USING COMPUTER-PERFORMED OPTICAL ANALYSIS OF CT OF THE LIVER (FibroCT®)
  121. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations
  122. Effect of defunctionalization on colon carcinogenesis in the rat
  123. Lower GI bleeding secondary to a stromal rectal tumor (rectal GIST)
  124. 93 Amoxicillin-clavulanate (AC) associated hepatotoxicity: Analysis of a single country large cohort prospectively identified
  125. 669 Chronic liver damage after an episode of idiosyncratic drug induced liver injury (DILI)
  126. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
  127. Celiac disease
  128. Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response
  129. Usefulness of duodenal biopsy during routine upper gastrointestinal endoscopy for diagnosis of celiac disease
  130. A Nationwide Study of Mortality Associated with Hospital Admission Due to Severe Gastrointestinal Events and Those Associated with Nonsteroidal Antiinflammatory Drug Use
  131. Protective Effect of the HLA‐Bw4I80 Epitope and the Killer Cell Immunoglobulin‐Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection
  132. Use of Low Concentrations of Human IgA Anti-Tissue Transglutaminase to Rule Out Selective IgA Deficiency in Patients with Suspected Celiac Disease,
  133. Impairment of Health-Related Quality of Life in Patients With Inflammatory Bowel Disease: a Spanish Multicenter Study
  134. Association of Helicobacter pylori-related Distal Gastric Cancer with the HLA Class II Gene DQB1*0602 and cagA+ Strains in a Southern European Population
  135. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice
  136. Response to Dr. Bogdanos
  137. MHC Class I Region Plays a Role in the Development of Diverse Clinical forms of Celiac Disease in a Saharawi Population
  138. Severe toxic hepatitis related to chlormethiazole
  139. Overview of JET results
  140. Comparative study of the efficacy of an induction dose of interferon-alpha2b with ribavirin compared with standard combined treatment in naive patients with chronic hepatitis C
  141. TNF-$alpha; $minus;308A promoter polymorphism is associated with enhanced TNF-$alpha; production and inflammatory activity in Crohn?s patients with fistulizing disease
  142. Extended HLA haplotype EH18. 1 influences the progression to hepatocellular carcinoma in patients with hepatitis C virus infection
  143. HLA class II molecules and drug-induced idiosyncratic liver disease. A multicenter study
  144. Levosulpiride in the treatment of dysmotility-like functional dyspepsia: Randomised double-dimmed comparison with cisapride
  145. MHC class I chain-like gene A (MICA) trinucleotide repeat polymorphism is associated with disease susceptibility and behavior in ulcerative colitis
  146. Retreatment and maintenance therapy with infliximab in fistulising Crohn's disease
  147. MICB typing by PCR amplification with sequence specific primers
  148. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis
  149. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis
  150. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results
  151. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial
  152. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease
  153. High serum tumor necrosis factor-α levels are associated with lack of response to infliximab in fistulizing Crohn's disease
  154. Autoantibodies to Golgi proteins in hepatocellular carcinoma: case report and literature review
  155. Acute Hepatitis Associated With Cetirizine Intake
  156. MHC class I chain related gene A (MICA) modulates the development of coeliac disease in patients with the high risk heterodimer DQA1*0501/DQB1*0201
  157. Current concepts in the management of Helicobacter pylori infection-The Maastricht 2-2000 Consensus Report
  158. MICA-A5.1 allele is associated with atypical forms of celiac disease in HLA-DQ2-negative patients
  159. The relationship of overweight and obesity with subjective health and use of health-care services among Spanish women
  160. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders
  161. Nimesulide-Induced Severe Hemolytic Anemia and Acute Liver Failure Leading to Liver Transplantation
  162. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine
  163. Clinical efficacy of the Toupet technique performed by laparoscopic surgery
  164. Nodular Regenerative Hyperplasia of the Liver in a Patient With Celiac Disease
  165. Antilactoferrin antibodies in autoimmune liver disease
  166. Prevalence of hepatitis C virus infection in the general population of northern Spain
  167. A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia
  168. Hepatitis aguda por ticlopidina. Presentación de 12 casos y revisión de la literatura
  169. Letters to the Editor
  170. Diagnostic value of adenosine deaminase isoenzymes in ascitic fluid
  171. Aging characteristics of Zr–V–Fe getters as observed by Mössbauer spectroscopy
  172. Tamoxifen Does Not Improve Survival of Patients With Advanced Hepatocellular Carcinoma
  173. Clinical efficacy and safety of pantoprazole versus ranitidine in patients with acute duodenal ulcer: Spanish multicenter study
  174. Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial
  175. Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer
  176. Characterization of Deactivated Metal Getters Used in a Glove Box Purification System
  177. Characterization of Tritiated Hydrocarbon Species and Measurement of Their Concentrations in Air during Vacuum Pump Maintenance
  178. Experimental Demonstration of the HITEX Process for Fusion Fuel Clean-Up
  179. Measurement of Tritium on Surfaces
  180. First Results of the TJ-I U Torsatron
  181. Clinical efficacy of intramuscular human interferon-β vs interferon-α2b for the treatment of chronic hepatitis C
  182. Acute exacerbations in chronic HBsAg carriers: is HCV implicated?
  183. Limitations of serological assays for hepatitis C virus screening in blood donors
  184. Pneumopericardium without subcutaneous emphysema, pneumomediastinum, or pneumothorax after laparoscopy
  185. Response related factors in recombinant interferon alfa-2b treatment of chronic hepatitis C.
  186. Treatment of chronic hepatitis C with recombinant interferon alfa-2b for nine months.
  187. Hepatitis C virus infection in patients with acute hepatitis B
  188. Tritium Measurement and Monitoring in Experimental and Process Systems with Ionization Chambers
  189. Second-Generation Tests for Hepatitis C Virus
  190. Intrafamilial spread of hepatitis C virus
  191. Unusual foreign body protruding into the duodenum
  192. Hepatitis Delta Virus Infection and Acute HBsAg-Negative Hepatitis B
  193. Serum and bile modifications in the guinea-pig following chronic treatment with PGE1 and PGE2
  194. Diet and Colon Cancer
  195. Hereditary hemochromatosis